How Transdigm TDG translates market opportunities into growth 353 20260506 HR Healthcare posts 745 percent Q4 2025 EPS surprise yet shares dip 07 percent in daily trading NPAC New leadership details longterm growth roadmap as it evaluates potential acquisition targets TPST Tempest Therapeutics climbs 251 percent following narrow Q4 2025 EPS beat that lifts investor sentiment